VistaLifeSciences logo


ANAM is an FDA cleared and listed device for use in the assessment of cognitive function. It is a proven technology with over 30 years of demonstrated effectiveness in both healthy and clinical populations.

Studies have evaluated cognitive function or changes in cognition associated with:

  • Alzheimer's Disease
  • Athlete Injury and Fitness
  • Dementia
  • Cancer
  • Environmental Stressors
  • Exercise
  • Fatigue/Sleep Deprivation
  • Fibromyalgia
  • Lupus
  • Medications/Therapeutics
  • Migraine headaches
  • Multiple Sclerosis
  • Parkinson's Disease
  • Performance Capabilities
  • Readiness-to-Perform
  • Stress
  • Sustained Operations
  • Toxic Exposures
  • Traumatic Brain Injury (TBI)

For more information, see Research and Publications.